BRAF and ACTH-producing pituitary gland adenoma: Moreover, compared to wild-type cells, primary cultured human corticotroph adenoma cells with BRAF mutations displayed greater reduction of ACTH secretion in response to the BRAF inhibitor vemurafenib.